ATE509616T1 - Topische pharmazeutische und/oder cosmetische dosierungssysteme - Google Patents

Topische pharmazeutische und/oder cosmetische dosierungssysteme

Info

Publication number
ATE509616T1
ATE509616T1 AT04704643T AT04704643T ATE509616T1 AT E509616 T1 ATE509616 T1 AT E509616T1 AT 04704643 T AT04704643 T AT 04704643T AT 04704643 T AT04704643 T AT 04704643T AT E509616 T1 ATE509616 T1 AT E509616T1
Authority
AT
Austria
Prior art keywords
formulations
topical pharmaceutical
dosage systems
cosmetic dosage
dispense
Prior art date
Application number
AT04704643T
Other languages
English (en)
Inventor
Koral Embil
Sergio Nacht
Original Assignee
Edko Pazarlama Tanitim Ticaret Ltd Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edko Pazarlama Tanitim Ticaret Ltd Sirketi filed Critical Edko Pazarlama Tanitim Ticaret Ltd Sirketi
Application granted granted Critical
Publication of ATE509616T1 publication Critical patent/ATE509616T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3283—Cylindrical or polygonal containers, e.g. bottles, with two or more substantially axially offset, side-by-side compartments for simultaneous dispensing
    • B65D81/3288—Cylindrical or polygonal containers, e.g. bottles, with two or more substantially axially offset, side-by-side compartments for simultaneous dispensing composed of two or more separate containers joined to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04704643T 2003-01-23 2004-01-23 Topische pharmazeutische und/oder cosmetische dosierungssysteme ATE509616T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0301577.3A GB0301577D0 (en) 2003-01-23 2003-01-23 Topical pharmaceutical and/or cosmetic dispense systems
PCT/GB2004/000288 WO2004064803A1 (en) 2003-01-23 2004-01-23 Topical pharmaceutical and/or cosmetic dispense systems

Publications (1)

Publication Number Publication Date
ATE509616T1 true ATE509616T1 (de) 2011-06-15

Family

ID=9951680

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04704643T ATE509616T1 (de) 2003-01-23 2004-01-23 Topische pharmazeutische und/oder cosmetische dosierungssysteme

Country Status (17)

Country Link
US (1) US20040157766A1 (de)
EP (1) EP1589945B1 (de)
JP (1) JP4898423B2 (de)
KR (1) KR101224065B1 (de)
CN (1) CN1764437B (de)
AT (1) ATE509616T1 (de)
AU (1) AU2004206101B2 (de)
BR (1) BRPI0406911A (de)
CA (1) CA2514019C (de)
DK (1) DK1589945T3 (de)
EA (1) EA008813B1 (de)
GB (1) GB0301577D0 (de)
MA (1) MA27586A1 (de)
MX (1) MXPA05007785A (de)
NZ (1) NZ541370A (de)
WO (1) WO2004064803A1 (de)
ZA (1) ZA200505925B (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
ATE467411T1 (de) * 2004-11-09 2010-05-15 Imaginative Res Associates Inc Retinoidlösungen und formulierungen daraus
WO2007017901A2 (en) * 2005-06-08 2007-02-15 Khandelwal Sanjeev Silver nanoparticle dispersion formulation
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
EP2431089A1 (de) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metalloxidbeschichtung von wasserunlöslichen Inhaltsstoffen
DE602005008964D1 (de) * 2005-09-16 2008-09-25 Italfar Societa A Responsabili Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine
US8147815B2 (en) 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
WO2007092312A2 (en) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
EP2010133B1 (de) 2006-03-31 2016-05-04 Stiefel Research Australia Pty Ltd Formbares suspensionsgel
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
AU2007274081B2 (en) * 2006-07-12 2012-08-02 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US8080537B2 (en) * 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
MX2009000890A (es) * 2006-07-24 2009-02-05 Amcol International Corp Sistema de suministro y metodo de fabricacion del mismo.
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US8323672B2 (en) 2006-08-29 2012-12-04 Karykion Corporation Method of removing ticks from the skin and reducing the risk of bites
US7604814B2 (en) * 2006-08-29 2009-10-20 Karykion Inc. Method of removing ticks from the epidermal tissue of humans and other mammals
GB0618697D0 (en) * 2006-09-22 2006-11-01 Syntopix Ltd Formulations
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
JP2010517996A (ja) 2007-02-01 2010-05-27 ソル − ゲル テクノロジーズ リミテッド 過酸化物及びレチノイドを含む局所適用用組成物
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US7726487B2 (en) * 2007-02-09 2010-06-01 Mcneil-Ppc, Inc. Complementary personal lubricant compositions
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
US8275441B2 (en) * 2007-11-02 2012-09-25 Tyco Healthcare Group Lp Electrodes possessing change indicator
JP2011510999A (ja) * 2008-02-01 2011-04-07 アンコル インターナショナル コーポレイション 改良された皮膚美白組成物
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
MX2010012753A (es) * 2008-05-30 2010-12-21 Galderma Res & Dev Composiciones despigmentantes anhidras que comprenden, dentro de la fase grasa, un derivado fenolico solubilizado y un retinoide.
US7740886B1 (en) * 2008-07-11 2010-06-22 Sara Vargas Bedsore treatment ointment
WO2010033408A1 (en) * 2008-09-17 2010-03-25 Mcgrath Patrick D Antimicrobial sucralfate paste methods and compositions
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
MX2011005010A (es) * 2009-01-05 2011-05-30 Sol Gel Technologies Ltd Composiciones topicas que contienen agentes activos recubiertos.
EP2387473B1 (de) 2009-01-16 2013-11-06 Colgate-Palmolive Company Austragbehälter mit einem eine pumpe aufnehmenden anschlussstück
WO2011101868A2 (en) * 2010-02-18 2011-08-25 Helios Pharmaceuticals Private Limited Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
US20120064135A1 (en) * 2010-09-15 2012-03-15 Norac Pharma Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
CN102475681A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 治疗皮肤病的分离式水混悬剂药物
CN102600205B (zh) * 2011-01-19 2013-06-05 杨光明 一种治疗寻常性痤疮的“锌红过氧化苯甲酰”凝胶及其制备方法
JP2014518265A (ja) * 2011-06-30 2014-07-28 アラーガン インコーポレイテッド レチノイド局所用組成物および皮膚疾病を治療するための方法
BR112015000036A2 (pt) * 2012-07-05 2017-06-27 Wrigley W M Jun Co bases de goma à base de micropartículas poliméricas reticuladas
CN102961250B (zh) * 2012-10-10 2014-12-10 江苏山信药业有限公司 一种多组份容器及治疗痤疮的外用制剂
CA2889199C (en) * 2012-11-27 2020-05-19 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2015066717A1 (en) 2013-11-04 2015-05-07 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
PH12014000195B1 (en) * 2014-07-10 2023-06-30 D&L Ind Inc Composition of medium chain triglycerides containing substantial amount of lauric acid
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
US20230120120A1 (en) * 2016-11-18 2023-04-20 Cutting Edge Technology, LLC Pharmaceutical formulation
MX395001B (es) * 2017-03-08 2025-03-24 Centro Int De Cosmiatria S A P I De C V Composición y método para el tratamiento tópico del acné severo.
EP3651756B1 (de) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Zusammensetzungen mit verkapseltem tretinoin
MX390288B (es) * 2018-02-06 2025-03-20 Centro Int De Cosmiatria S A P I De C V Formulación y método para el tratamiento de la alopecia androgénica.
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US20220175802A1 (en) * 2019-03-19 2022-06-09 Sol-Gel Technologies Ltd. Combination of minocycline and benzoyl peroxide and method of use thereof
CN113891697B (zh) * 2019-03-28 2025-03-18 特清公司 用于眼用制剂的流量控制的装置和方法
CA3150161A1 (en) 2019-08-13 2021-02-18 Darlene E. MCCORD Non-activated, amorphous, ph neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
JP2023539106A (ja) * 2020-08-19 2023-09-13 サイトソーベンツ・コーポレーション 治療的および美容的な創傷処置法
EP4423197A4 (de) 2021-10-25 2025-08-27 Darlene E Mccord Beschichtete medizinische tonzusammensetzungen, pharmazeutische zusammensetzungen und abgabe von kationenquellen und verfahren zur verwendung davon
WO2023112664A1 (ja) * 2021-12-14 2023-06-22 ロート製薬株式会社 過酸化ベンゾイルを含有する医薬外用組成物

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535422A (en) * 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4228163A (en) * 1979-03-30 1980-10-14 Dermik Laboratories Method for treating pseudofolliculitis barbae
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
IT1210608B (it) * 1980-12-08 1989-09-14 Rorer Int Overseas Composizione per il trattamento topico dell'acne
US4692329A (en) * 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
WO1983002558A1 (en) * 1981-11-09 1983-08-04 Gail Sansone Bazzano The use of retinoids and minoxidil (2,4,-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias
US4923900A (en) * 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5955109A (en) * 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4873091A (en) * 1988-05-23 1989-10-10 Advanced Polymer Systems, Inc. Controlled release formulating employing resilient microbeads
US4962170A (en) * 1989-08-31 1990-10-09 Dow Corning Corporation Method of making highly absorptive polymers
US4962133A (en) * 1989-09-05 1990-10-09 Dow Corning Corporation Method of making highly adsorptive copolymers
CA2015111A1 (en) * 1990-04-23 1991-10-23 Tom Y. Woo New binary dispensor for the application of fluids, semi-fluids or semi-solids
US5256400A (en) * 1991-12-04 1993-10-26 Advanced Polymer Systems, Inc. Pressurized product delivery systems
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
US5356040A (en) * 1992-03-31 1994-10-18 Maplast S.R.L. Container particulary for multicomponent products
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5837790A (en) * 1994-10-24 1998-11-17 Amcol International Corporation Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
US5712358A (en) * 1995-06-07 1998-01-27 Amcol International Corporation Process for producing an oil sorbent copolymer and the product thereof
JPH09226852A (ja) * 1996-02-28 1997-09-02 Cci Corp 塗布容器
JPH11222272A (ja) * 1998-02-02 1999-08-17 Tombow Pencil Co Ltd 液体のり容器
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
US6110446A (en) * 1998-10-05 2000-08-29 Colgate Palmolive Company Dual component antiplaque and tooth whitening composition
US6007264A (en) * 1998-12-02 1999-12-28 Felix Investments, Llc Integral package applicator
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP1335693A2 (de) * 2000-04-21 2003-08-20 Sol-Gel Technologies Ltd. Zusammensetzung mit erhöhter formulationsstabilität und verabreichung von topischen wirkstoffen
AU2001275201A1 (en) * 2000-06-02 2001-12-11 Dermik International Holding Inc. Acne-treating composition
JP4580524B2 (ja) * 2000-09-12 2010-11-17 株式会社日本点眼薬研究所 フィルター付き吐出容器
US6462025B2 (en) * 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US6544562B2 (en) * 2001-06-25 2003-04-08 Blistex Inc. Acne treatment including dual-package system

Also Published As

Publication number Publication date
ZA200505925B (en) 2006-11-29
EP1589945A1 (de) 2005-11-02
GB0301577D0 (en) 2003-02-26
CN1764437A (zh) 2006-04-26
CA2514019C (en) 2012-02-28
MXPA05007785A (es) 2006-05-04
CN1764437B (zh) 2010-05-12
AU2004206101A1 (en) 2004-08-05
BRPI0406911A (pt) 2006-01-03
NZ541370A (en) 2008-08-29
WO2004064803A1 (en) 2004-08-05
KR101224065B1 (ko) 2013-01-21
JP4898423B2 (ja) 2012-03-14
EA200501107A1 (ru) 2006-02-24
MA27586A1 (fr) 2005-10-03
HK1088540A1 (zh) 2006-11-10
US20040157766A1 (en) 2004-08-12
EP1589945B1 (de) 2011-05-18
DK1589945T3 (da) 2011-09-05
AU2004206101A2 (en) 2004-08-05
KR20050105442A (ko) 2005-11-04
EA008813B1 (ru) 2007-08-31
AU2004206101B2 (en) 2010-06-24
JP2006519178A (ja) 2006-08-24
CA2514019A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
ATE509616T1 (de) Topische pharmazeutische und/oder cosmetische dosierungssysteme
SE0003449D0 (sv) Anticancer compositions
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ATE356612T1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
MXPA05010565A (es) Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado.
EA200401252A1 (ru) Микрочастицы лекарственных веществ
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
WO2005046640A3 (en) Multi-site drug delivery platform
MX2023006414A (es) Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
JOP20240078A1 (ar) تركيبات إردافيتينيب وأنظمة الإعطاء داخل المثانة
CY1107295T1 (el) Σταθεροποιηση στερεων φορμουλων φαρμακων του θυρεοειδους
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
CO5650216A2 (es) Estuche para uso farmaceutico
WO2006060325A3 (en) Coated drug delivery formulations
SE9301877D0 (sv) In situ gel for therapeutic use
TN2010000008A1 (en) Oral pharmaceutical solutions containing telbivudine
AU2002328873A1 (en) Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane
ATE442864T1 (de) Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties